成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天
TargetMol Chemicals Inc. Company Information
Company Name:
TargetMol Chemicals Inc.
Tel:
+1-781-999-5354
Email:
marketing@targetmol.com
Nationality:
United States
WebSite:
https://www.targetmol.com/
Product List:
32161
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
Product List
McMMAF
863971-19-1
Meleagrin
71751-77-4
Meclinertant
146362-70-1
MDL 105519
161230-88-2
ME1111
1391758-52-3
(Z)-MDL 105519
179105-67-0
Mcl1-IN-1
713492-66-1
MCI826
140646-80-6
SGD-1910;MC-Val-Ala-PBD
1342820-51-2
Glipizide
29094-61-9
CLZ-8
678158-55-9
IMB-XH1
292057-76-2
Mcl1-IN-3
1814891-79-6
MC-GGFG-DX8951
1600418-29-8
Melinamide;DL-N-(α-Methylbenzyl)linoleamide;AC 223
14417-88-0
Ibodutant;MEN 15596
522664-63-7
GLN-1062
224169-27-1
Men 10376
135306-85-3
Tiratricol
51-24-1
Mepazine
60-89-9
Doxifluridine
3094-09-5
MALAT1-IN-1
827327-28-6
Mal-Sulfo-DBCO
2028281-86-7
Mal-PEG8-NHS ester
2055033-05-9
Mal-PEG8-Boc
2055048-43-4
Mal-PEG8-acid
1818294-46-0
Mal-PEG6-PFP ester
1599486-33-5
Mal-PEG6-NHS ester
1599472-25-9
Managlinat dialanetil
280782-97-0
Marizomib
437742-34-2
Lomustine
13010-47-4
MAT2A inhibitor 1
2201057-10-3
Manumycin A
52665-74-4
Mancozeb
8018-01-7
Arhalofenate
24136-23-0
(24S)-MC 976
112849-14-6
(24R)-MC 976
112828-09-8
MC 976
129831-99-8
MB-07803
882757-24-6
MB-7133
685111-92-6
MB05032
261365-11-1
Maytansinol
57103-68-1
MB-07811
852948-13-1
MBQ-167
2097938-73-1
Valproic acid sodium salt
1069-66-5
Maxacalcitol;22-Oxacalcitriol
103909-75-7
Mavatrep;JNJ-39439335
956274-94-5
Maleimido-tri(ethylene glycol)-propionic acid;Mal-PEG3-acid
518044-40-1
Ibandronate sodium;Bondronat;Boniva;Ibandronate sodium salt
138844-81-2
Mal-PEG6-Boc
518044-37-6
Mal-PEG5-acid
1286755-26-7
Mal-PEG4-Val-Cit-PAB-PNP
2112738-09-5
Mal-PEG4-Val-Cit-PAB-OH
2055041-39-7
Mal-PEG5-NHS ester
1807537-42-3
Mal-PEG5-PFP ester
1807512-46-4
Mal-PEG6-acid
518044-42-3
Mal-C6-amine TFA
731862-92-3
Mal-PEG1-Boc
810677-16-8
Mal-PEG1-bromide
1823885-81-9
Mal-PEG1-NHS ester
1807518-72-4
Mal-PEG4-NHS ester
1325208-25-0
Mal-PEG4-PFP ester
1415800-42-8
Mal-PEG4-OH
1421933-37-0
Mal-PEG4-Boc
518044-36-5
Mal-PEG4-acid
518044-41-2
Mal-PEG3-PFP ester
1807534-78-6
Mal-PEG3-NHS ester
1537892-36-6
Mal-PEG3-Boc
518044-35-4
Mal-PEG3-alcohol
146551-23-7
Mal-PEG2-Val-Cit-amido-PAB-OH
2055041-38-6
Mal-PEG2-PFP ester
1807512-47-5
Mal-PEG2-NHS ester
1433997-01-3
Mal-PEG2-NH2
660843-22-1
Mal-N-bis(PEG4-C2-acid)
2100306-52-1
Proadifen hydrochloride
62-68-0
Rimantadine hydrochloride
1501-84-4
Mal-PEG2-NH-Boc
660843-21-0
Mal-PEG2-alcohol
34321-81-8
Mal-PEG2-acid
1374666-32-6
Mal-PEG1-PFP ester
1807530-08-0
Mal-NH-Boc
134272-63-2
Mal-NH-ethyl-SS-propionic acid
2128735-24-8
Mal-NH2 TFA
146474-00-2
Mal-PEG1-acid
760952-64-5
Methylamino-PEG3-azide
1355197-57-7
Methylamino-PEG4-Boc;Methylamino-PEG4-t-butyl ester
1621616-14-5
Methylamino-PEG5-azide
2055046-24-5
Methyltetrazine-acid
1380500-88-8
Methylamino-PEG4-acid
1283658-71-8
Mepixanox;Pimexone
17854-59-0
Metaproterenol;Orciprenaline
586-06-1
Metaldehyde
108-62-3
Methoprene
40596-69-8
Methyl propionate-PEG12
1239588-11-4
Methylamino-PEG1-acid
1367918-21-5
Methylamino-PEG1-Boc;Methylamino-PEG1-t-butyl ester
1807521-03-4
Methylamino-PEG2-acid
1807503-87-2
Methylamino-PEG2-Boc;Methylamino-PEG2-t-butyl ester
1807521-04-5
Methotrexate metabolite
19741-14-1
Enalapril
75847-73-3
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
Copyright 2007© ChemicalBook. All rights reserved.